Latest News
Alvotech and Teva secure US launch date for Eylea biosimilar AVT06
19 December 2025 - European biotechnology company Alvotech S.A. (NASDAQ: ALVO) and Teva Pharmaceuticals, a US affiliate of Israeli drugmaker Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), on Friday said they have reached a settlement and ...
Egetis initiates rolling US NDA for Emcitate in MCT8 deficiency
19 December 2025 - Swedish pharmaceutical company Egetis Therapeutics AB (STO:EGTX) said on Friday that it has initiated a rolling New Drug Application submission to the U.S. Food and Drug Administration for Emcitate (tiratricol), an investigational ...
Ipsen closes Phase II FALKON trial after missing primary endpoint in FOP
19 December 2025 - French biopharmaceutical company Ipsen (Euronext Paris:IPN) (ADR:IPSEY) reported on Friday that its pivotal Phase II FALKON trial in fibrodysplasia ossificans progressiva (FOP) did not meet the primary endpoint of reducing new hete...
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
19 December 2025 - Global healthcare company Abbott (NYSE:ABT) announced on Thursday that it has received US Food and Drug Administration (FDA) approval and CE Mark for its Amplatzer Piccolo Delivery System, which is used with its Amplatzer Piccolo O...
Century Health partnerss with Tessel Biosciences to advance early drug development in COPD
19 December 2025 - Health technology company Century Health announced on Thursday that it has partnered with Tessel Biosciences, a US-based biotechnology company that combines human organoids and machine learning to model chronic disease.Under the co...